MISSISSAUGA, Ontario, July 11, 2006 (PRIMEZONE) -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article by Glenn Wilkins, an AllPennyStocks.com News Reporter, this one discussing BioElectronics Corp. (Pink Sheets:BIEL), its industry and future prospects.
Wilkins notes that in our mysteriously shrinking planet, some of the most innovative ideas for safeguarding our health and well-being involve medicines and preventive measures that are smaller and thereby are less obtrusive, besides being more convenient, not to mention cheaper.
Wilkins also points out that such is the technology on which BioElectronics Corp. has staked its career. The Company out of Frederick, Maryland is in the business of creating revolutionary new products by miniaturizing therapeutic application disposable, cost-effective dermal patches. Among those products is ActiPatch, recently approved by government health officials in Canada; a drug-free, anti-inflammatory patch for the relief of pain from stress, strains and sprains.
The full version of this special report on BIEL can be found at:
http://www.allpennystocks.com/apsc/us/article/biel_july_10_2006.htm
About AllPennyStocks.com:
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and U.S. site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs weekly stocks to watch, has a weekly market write-up, provides company spotlights, runs a unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, Nasdaq and OTC BB, and much more information for the average investor.
Although the majority of AllPennyStocks.com reports are independent, it has received compensation for carrying the report on BioElectronics Corp. (Pink Sheets:BIEL), the compensation is five thousand dollars by a non-affiliated third-party, SmallCapVoice.com for its efforts in presenting the BIEL profile on its web site and distributing it to its database of subscribers as well as other services. This creates an inherent conflict of interest and readers are encouraged to view the main disclaimer at http://www.allpennystocks.com/apsc/us/stock_profiles/biel.htm.